BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33106929)

  • 1. Biologic therapy in Sjögren's syndrome.
    Shao Q
    Clin Rheumatol; 2021 Jun; 40(6):2143-2154. PubMed ID: 33106929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in imaging of the lacrimal gland in Sjögren's syndrome: A narrative review.
    Zhong W; Zhang H; Ran H
    J Clin Ultrasound; 2024 Jan; 52(1):68-77. PubMed ID: 37907965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.
    Abughanam G; Elkashty OA; Liu Y; Bakkar MO; Tran SD
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
    Wang SQ; Wang YX; Hua H
    Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Workshop on Oral Medicine VII: Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review.
    Gueiros LA; France K; Posey R; Mays JW; Carey B; Sollecito TP; Setterfield J; Woo SB; Culton D; Payne AS; Lodi G; Greenberg MS; De Rossi S
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):102-110. PubMed ID: 31140693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms Linking Inflammation to Autoimmunity in Sjögren's Syndrome: Identification of New Targets.
    Sisto M; Ribatti D; Lisi S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of genes potentially related to hyposecretion in male non-obese diabetic (NOD) mice, a Sjögren's syndrome model.
    Ohno Y; Satoh K; Kashimata M
    J Oral Biosci; 2023 Sep; 65(3):211-217. PubMed ID: 37209839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
    Soyfoo MS; Chivasso C; Perret J; Delporte C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Zhou H; Yang J; Tian J; Wang S
    Front Immunol; 2020; 11():602823. PubMed ID: 33584670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarials in Sjögren's syndrome--the Greek experience.
    Manoussakis MN; Moutsopoulos HM
    Lupus; 1996 Jun; 5 Suppl 1():S28-30. PubMed ID: 8803907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome.
    Sarrand J; Baglione L; Parisis D; Soyfoo M
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of sex steroids on Sjögren's syndrome.
    Porola P; Laine M; Virkki L; Poduval P; Konttinen YT
    Ann N Y Acad Sci; 2007 Jun; 1108():426-32. PubMed ID: 17894007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren's Syndrome Based on the PI3K/Akt/HIF-1
    Zeng P; Liu W; Yang X; Zhang S; Du S; Fan Y; Zhao L; Wang A
    Dis Markers; 2022; 2022():6153459. PubMed ID: 35140821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
    Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
    J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
    Al-Hashimi I
    Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Glimpse Into the Microbiome of Sjögren's Syndrome.
    Deng C; Xiao Q; Fei Y
    Front Immunol; 2022; 13():918619. PubMed ID: 35911741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.
    Generali E; Costanzo A; Mainetti C; Selmi C
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):357-370. PubMed ID: 28871434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjögren's syndrome in older patients: aetiology, diagnosis and management.
    Moerman RV; Bootsma H; Kroese FG; Vissink A
    Drugs Aging; 2013 Mar; 30(3):137-53. PubMed ID: 23341116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus.
    Hsu S; Dickinson D
    J Biochem Mol Biol; 2006 May; 39(3):229-39. PubMed ID: 16756750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.